Person:
Larvie, Mykol

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Larvie

First Name

Mykol

Name

Larvie, Mykol
Author's Publications: search.filters.isAuthorOfPublication.b93a8f05-aacd-4f04-ae3a-d744b99ff196

Search Results

Now showing 1 - 5 of 5
  • Thumbnail Image
    Publication
    Teaching NeuroImages: Apathetic variant of frontotemporal dementia
    (Ovid Technologies (Wolters Kluwer Health), 2011) Perez, D. L.; Larvie, Mykol; Acar, Diler; Daffner, Kirk
  • Thumbnail Image
    Publication
    Optimal Brain MRI Protocol for New Neurological Complaint
    (Public Library of Science, 2014) Mehan, William; González, R. Gilberto; Buchbinder, Bradley; Chen, John; Copen, William; Gupta, Rajiv; Hirsch, Joshua; Hunter, George; Hunter, Scott; Johnson, Jason M.; Kelly, Hillary R.; Larvie, Mykol; Lev, Michael; Pomerantz, Stuart; Rapalino, Otto; Rincon, Sandra; Romero, Javier; Schaefer, Pamela; Shah, Vinil
    Background/Purpose Patients with neurologic complaints are imaged with MRI protocols that may include many pulse sequences. It has not been documented which sequences are essential. We assessed the diagnostic accuracy of a limited number of sequences in patients with new neurologic complaints. Methods: 996 consecutive brain MRI studies from patients with new neurological complaints were divided into 2 groups. In group 1, reviewers used a 3-sequence set that included sagittal T1-weighted, axial T2-weighted fluid-attenuated inversion recovery, and axial diffusion-weighted images. Subsequently, another group of studies were reviewed using axial susceptibility-weighted images in addition to the 3 sequences. The reference standard was the study's official report. Discrepancies between the limited sequence review and the reference standard including Level I findings (that may require immediate change in patient management) were identified. Results: There were 84 major findings in 497 studies in group 1 with 21 not identified in the limited sequence evaluations: 12 enhancing lesions and 3 vascular abnormalities identified on MR angiography. The 3-sequence set did not reveal microhemorrhagic foci in 15 of 19 studies. There were 117 major findings in 499 studies in group 2 with 19 not identified on the 4-sequence set: 17 enhancing lesions and 2 vascular lesions identified on angiography. All 87 Level I findings were identified using limited sequence (56 acute infarcts, 16 hemorrhages, and 15 mass lesions). Conclusion: A 4-pulse sequence brain MRI study is sufficient to evaluate patients with a new neurological complaint except when contrast or angiography is indicated.
  • Thumbnail Image
    Publication
    Quantitative Analysis of Metabolic Abnormality Associated with Brain Developmental Venous Anomalies
    (Cureus, 2016) Timerman, Dmitriy; Thum, Jasmine A; Larvie, Mykol
    Background and Purpose: Abnormal hypometabolism is common in the brain parenchyma surrounding developmental venous anomalies (DVAs), although the degree of DVA-associated hypometabolism (DVAAh) has not been quantitatively analyzed. In this study, we demonstrate a simple method for the measurement of DVAAh and test the hypothesis that DVAs are associated with a quantifiable decrement in metabolic activity. Materials and Methods: Measurements of DVAAh using ratios of standardized uptake values (SUVs) and comparison to a normal database were performed on a cohort of 25 patients (12 male, 13 female), 14 to 76 years old, with a total of 28 DVAs (20 with DVAAh, seven with isometabolic activity, and one with hypermetabolic activity). Results: Qualitative classification of none, mild, moderate, and severe DVAAh corresponded to quantitative measurements of DVAAh of 1 ± 3%, 12 ± 7%, 18 ± 6%, and 37 ± 6%, respectively. A statistically significant linear correlation between DVAAh and age was observed (P = 0.003), with a 3% reduction in metabolic activity per decade. A statistically significant linear correlation between DVAAh and DVA size was observed (P = 0.01), with a 4% reduction in metabolic activity per each 1 cm in the longest dimension. The SUVDVA-based measures of DVAAh correlated (P = 0.001) with measures derived from comparison with a standardized database. Conclusion: We present a simple method for the quantitative measurement of DVAAh using ratios of SUVs, and find that this quantitative analysis is consistent with a qualitative classification. We find that 54% (15 of 28) of DVAs are associated with a greater than 10% decrease in metabolic activity.
  • Thumbnail Image
    Publication
    The Massachusetts General Hospital Acute Stroke Imaging Algorithm: An Experience and Evidence Based Approach
    (BMJ Publishing Group, 2013) Gonzalez, Ramon; Copen, William; Schaefer, Pamela; Lev, Michael; Pomerantz, Stuart; Rapalino, Otto; Chen, John; Hunter, George; Romero, Javier; Buchbinder, Bradley; Larvie, Mykol; Hirsch, Joshua; Gupta, Rajiv
    The Massachusetts General Hospital Neuroradiology Division employed an experience and evidence based approach to develop a neuroimaging algorithm to best select patients with severe ischemic strokes caused by anterior circulation occlusions (ACOs) for intravenous tissue plasminogen activator and endovascular treatment. Methods found to be of value included the National Institutes of Health Stroke Scale (NIHSS), non-contrast CT, CT angiography (CTA) and diffusion MRI. Perfusion imaging by CT and MRI were found to be unnecessary for safe and effective triage of patients with severe ACOs. An algorithm was adopted that includes: non-contrast CT to identify hemorrhage and large hypodensity followed by CTA to identify the ACO; diffusion MRI to estimate the core infarct; and NIHSS in conjunction with diffusion data to estimate the clinical penumbra.
  • Thumbnail Image
    Publication
    Mannose-Binding Lectin Binds to Amyloid \(\beta\) Protein and Modulates Inflammation
    (Hindawi Publishing Corporation, 2012) Larvie, Mykol; Shoup, Timothy; Chang, Wei-Chuan; Chigweshe, Lorencia; Hartshorn, Kevan; White, Mitchell R.; Stahl, Gregory L.; Elmaleh, David; Takahashi, Kazue
    Mannose-binding lectin (MBL), a soluble factor of the innate immune system, is a pattern recognition molecule with a number of known ligands, including viruses, bacteria, and molecules from abnormal self tissues. In addition to its role in immunity, MBL also functions in the maintenance of tissue homeostasis. We present evidence here that MBL binds to amyloid \(\beta\) peptides. MBL binding to other known carbohydrate ligands is calcium-dependent and has been attributed to the carbohydrate-recognition domain, a common feature of other C-type lectins. In contrast, we find that the features of MBL binding to A\(\beta\) are more similar to the reported binding characteristics of the cysteine-rich domain of the unrelated mannose receptor and therefore may involve the MBL cysteine-rich domain. Differences in MBL ligand binding may contribute to modulation of inflammatory response and may correlate with the function of MBL in processes such as coagulation and tissue homeostasis.